SEC Form D filing
UBIVAC, INC.
Biotech · Series A · Regulation D 506(b) · OR · Filed March 10, 2025
Offering amount
$4.5M
Exemption
Reg D 506(b)
Issuer state
OR
Filing date
March 10, 2025
Signature date
—
CIK
0001713945
Summary
UBIVAC vaccine biotech with $4.45M offering in series-a range.
Source
FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.